MediWound (MDWD) EPS (Weighted Average and Diluted) (2018 - 2025)
MediWound (MDWD) recorded quarterly EPS (Weighted Average and Diluted) of -$0.68 in Q4 2025, up 99.99% quarter-over-quarter from -$10186.2 in Q2 2025, and down 11.21% on a YoY basis from -$0.76 in Q4 2024.
MediWound (MDWD) EPS (Weighted Average and Diluted) (2018 - 2025) Analysis & Trends
MediWound's EPS (Weighted Average and Diluted) history runs 6 years deep, the most recent figure standing at -$0.68 for Q4 2025.
- In Q4 2025, EPS (Weighted Average and Diluted) fell 11.21% year-over-year to -$0.68; the TTM figure through Dec 2025 stood at -$0.68 (down 11.21% YoY), while the FY2025 annual figure was -$2.1, up 30.69% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.68 for Q4 2025 at MediWound, up from -$10186.2 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2937.5 in Q2 2023 to a low of -$10186.2 in Q2 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$1211.7 across 5 years, with a median of -$0.88 in 2022.
- The sharpest annual moves came in 2023 and 2024: EPS (Weighted Average and Diluted) surged 220.99% in 2023, then plunged 266.26% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.07 in 2021, then plunged by 37.72% to -$1.47 in 2022, then jumped by 88.65% to -$0.17 in 2023, then slumped by 266.26% to -$0.61 in 2024, then declined by 11.21% to -$0.68 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.68 (Q4 2025), -$10186.2 (Q2 2025), and -$0.61 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 0.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.61 |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -0.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.68 |
| Jun 30, 2025 | -10,186.15 |
| Dec 31, 2024 | -0.61 |
| Jun 30, 2024 | -3,646.82 |
| Dec 31, 2023 | -0.17 |
| Sep 30, 2023 | -0.23 |
| Jun 30, 2023 | 2,937.50 |
| Dec 31, 2022 | -1.47 |
| Sep 30, 2022 | -0.88 |
| Jun 30, 2022 | -2,427.93 |
| Dec 31, 2021 | -1.07 |
| Dec 31, 2018 | 2,611.76 |